These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4066443)

  • 1. Solid tumor models for the assessment of different treatment modalities: XXIII. A new approach to the more effective utilization of radiotherapy alternated with chemotherapy.
    Looney WB; Hopkins HA; Carter WH
    Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2105-17. PubMed ID: 4066443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid tumor models for the assessment of different treatment modalities: XXV. Comparison of the effect of one radiation fraction per day with multiple fractions per day (MFD) given either continuously or intermittently on tumor response and normal tissue reaction.
    Looney WB; Hopkins HA
    Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):203-10. PubMed ID: 3949571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapy.
    Looney WB; Hopkins HA; Carter WH
    Cancer; 1984 Aug; 54(3):416-25. PubMed ID: 6733674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid tumor models for the assessment of different treatment modalities. XXI. Comparison of different radiation dose schedules alone or in combination with cyclophosphamide.
    Looney WB; Longerbeam MB; Hopkins HA; Carter WH
    Cancer; 1983 Mar; 51(6):1012-20. PubMed ID: 6821865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid tumor models for the assessment of different treatment modalities: XXVI. Estimates of cell survival from tumor growth delay after alternating radiotherapy and chemotherapy.
    Hopkins HA; Looney WB
    Int J Radiat Oncol Biol Phys; 1987 Feb; 13(2):217-24. PubMed ID: 3818388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of daily versus hyperfractionated split-course radiation schedules with and without cyclophosphamide on median survival, metastatic dissemination, tumor cure, and growth rates.
    Looney WB; Hopkins HA; Longerbeam MB; Carter WH
    Cancer Res; 1983 Jan; 43(1):60-7. PubMed ID: 6847784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid tumor models for the assessment of different treatment modalities: XVI. Sequential combined modality (Cyclophosphamide-Radiation) therapy.
    Looney WB; Ritenour ER; Hopkins HA
    Cancer; 1981 Mar; 47(5):860-9. PubMed ID: 7226039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of radiation or cyclophosphamide versus alternated radiation and cyclophosphamide treatment of primary tumor and pulmonary metastases.
    Looney WB; Hopkins HA
    NCI Monogr; 1988; (6):145-6. PubMed ID: 3352757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of tumor regrowth to tumor cell survival, tumor cure rates and host survival in a solid tumor model following combined chemotherapy and radiotherapy.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):97-105. PubMed ID: 8054518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid tumor models for the assessment of different treatment modalities. XIX. Tumor cure rates and tumor control following sequential administration of radiation and cyclophosphamide.
    Looney WB; Ritenour ER; Hopkins HA
    Am J Clin Oncol; 1982 Apr; 5(2):209-20. PubMed ID: 7091043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid tumor models for the assessment of different treatment modalities. XIII. Comparison of response and recovery of host and solid tumor to cyclophosphamide and radiation.
    Looney WB; Hopkins HA; Grover WH; Macleod MS; Ritenour ER; Hobson AS
    Cancer; 1980 Jun; 45(11):2793-804. PubMed ID: 7379010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
    Lelieveld P; Scoles MA; Brown JM; Kallman RF
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy alternated with chemotherapy and immunotherapy on nude mice bearing human hepatocellular carcinoma].
    Bao YM
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):382-4. PubMed ID: 2470566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa.
    Van der Schueren E; Van den Bogaert W; Vanuytsel L; Van Limbergen E
    Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):301-11. PubMed ID: 2394609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental thermoradiotherapy in malignant hepatocellular carcinoma.
    Hehr T; Budach W; Lamprecht U; Belka C; Classen J; Trübenbach J; Wehrmann M; Dietz K; Bamberg M
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1374-80. PubMed ID: 12654450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalence of hyperfractionated and continuous brachytherapy in a rat tumor model and remarkable effectiveness when preceded by external irradiation.
    Veninga T; Visser AG; van den Berg AP; van Hooije CM; van Geel CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1351-60. PubMed ID: 11286843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined radiation and hyperthermia: comparison of two treatment schedules based on data from a registry established by the Radiation Therapy Oncology Group (RTOG).
    Luk KH; Francis ME; Perez CA; Johnson RJ
    Int J Radiat Oncol Biol Phys; 1984 Jun; 10(6):801-9. PubMed ID: 6735765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.